What is the functional/organic distinction actually doing in psychiatry and neurology?

Wellcome Open Research
Vaughan BellQuinton Deeley

Abstract

The functional-organic distinction aims to distinguish symptoms, signs, and syndromes that can be explained by diagnosable biological changes, from those that cannot. The distinction is central to clinical practice and is a key organising principle in diagnostic systems. Following a pragmatist approach that examines meaning through use, we examine how the functional-organic distinction is deployed and conceptualised in psychiatry and neurology. We note that the conceptual scope of the terms 'functional' and 'organic' varies considerably by context. Techniques for differentially diagnosing 'functional' and 'organic' diverge in the strength of evidence they produce as a necessary function of the syndrome in question. Clinicians do not agree on the meaning of the terms and report using them strategically. The distinction often relies on an implied model of 'zero sum' causality and encourages classification of syndromes into discrete 'functional' and 'organic' versions. Although this clearly applies in some instances, this is often in contrast to our best scientific understanding of neuropsychiatric disorders as arising from a dynamic interaction between personal, social and neuropathological factors. We also note 'functional' and ...Continue Reading

References

Jan 1, 1991·Scandinavian Journal of Gastroenterology. Supplement·J E Richter
Oct 1, 1990·The British Journal of Psychiatry : the Journal of Mental Science·E H Reynolds
Jan 1, 1991·Social Science & Medicine·S M Rosoff, M C Leone
Jan 1, 1989·The Journal of Neuropsychiatry and Clinical Neurosciences·S E StarksteinR G Robinson
Nov 4, 1988·Science·P S Churchland, T J Sejnowski
Aug 1, 1986·Journal of Neurology, Neurosurgery, and Psychiatry·B L MillerM Grode
Dec 2, 1967·Lancet·A B Carter
Jul 1, 1973·Journal of Autism and Childhood Schizophrenia·R M Kahn, M A Arbib
Apr 1, 1996·The Australian and New Zealand Journal of Psychiatry·P Sachdev
Sep 26, 1997·Movement Disorders : Official Journal of the Movement Disorder Society·J K Krauss, J Jankovic
Jul 22, 1998·The Psychiatric Clinics of North America·G R GeffkenD L Evans
Apr 18, 2000·Archives of Neurology·H Berry
Mar 21, 2001·Nature Reviews. Neuroscience·P W Halligan, A S David
Mar 1, 1996·History of Psychiatry·M D Beer
Mar 1, 1994·History of Psychiatry·G E Berrios, D Beer
May 3, 2002·The American Journal of Psychiatry·Joseph B Martin
Aug 17, 2002·Biological Psychiatry·Ellen M Whyte, Benoit H Mulsant
Aug 20, 2002·Journal of Neurology, Neurosurgery, and Psychiatry·J StoneM Sharpe
Sep 5, 2002·Movement Disorders : Official Journal of the Movement Disorder Society·Carolyn H Kwak, Joseph Jankovic
Oct 22, 2004·International Journal of Impotence Research·J M FarreM G Lasheras
May 2, 2006·The American Journal of Psychiatry·Marc J Miresco, Laurence J Kirmayer
Nov 23, 2006·Schizophrenia Bulletin·Peter J Uhlhaas, Aaron L Mishara
May 15, 2007·Frontiers of Neurology and Neuroscience·Thomas A PollakMark F Lythgoe
Jul 11, 2007·Epidemiologia e psichiatria sociale·Christina Katsakou, Stefan Priebe
Sep 14, 2007·Social Science & Medicine·Dag Album, Steinar Westin
Sep 14, 2007·Scandinavian Journal of Public Health·Marie Norredam, Dag Album
Feb 12, 2008·Movement Disorders : Official Journal of the Movement Disorder Society·Meritxell GomisJaune Roquer
Jul 9, 2008·Neuropsychological Rehabilitation·Giles Noel YeatesJoanna Collicutt McGrath
Mar 27, 2009·Brain : a Journal of Neurology·Richard KanaanSimon Wessely
Aug 8, 2009·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·Karine GouletJean-François Trudel
Aug 19, 2009·Journal of Health Psychology·Flora Cornish, Alex Gillespie
Oct 21, 2010·Journal of Medical Imaging and Radiation Oncology·Britta StrahlStephen L Stuckey
Apr 19, 2011·Journal of Clinical and Experimental Neuropsychology·Joseph BarrashDaniel Tranel
May 4, 2011·Brain Injury : [BI]·Nishant RanjanGuruprasad Venketswara
Jan 18, 2012·Journal of Neurology, Neurosurgery, and Psychiatry·Richard A KanaanSimon C Wessely
Feb 22, 2012·Journal of Cellular and Molecular Medicine·Isabelle LoubinouxAurel Popa-Wagner
Apr 19, 2012·JAMA : the Journal of the American Medical Association·Joe V SelbyLori Frank
Sep 11, 2012·Clinical Radiology·N KhandanpourD J A Connolly
Feb 14, 2013·The Australian and New Zealand Journal of Psychiatry·Thomas Ungar, Stephanie Knaak
Jul 12, 2013·Movement Disorders : Official Journal of the Movement Disorder Society·Mark J EdwardsAnthony E Lang
Jan 1, 1992·Journal of Cognitive Neuroscience·A Caramazza
Nov 2, 2013·European Psychiatry : the Journal of the Association of European Psychiatrists·T KieseppäE Isometsä
Jan 15, 2014·Neurocase·Akira Midorikawa, Mitsuru Kawamura

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.